Document is current
Any future updates will be listed below
-
Authors
Huang, Chengchi
Kaur, Avinash
Ji, Liyang
Tian, Hong
Webster, Keith A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY027749, R24EY028764, R21EY035421, R43EY031238, R43EY032827, R43EY031238, R43EY032827, R43EY031238)
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
U.S. Department of Health & Human Services | NIH | National Eye Institute
- License Information
-
More Information
Article History
Received: 20 February 2024
Revised: 18 September 2024
Accepted: 20 September 2024
First Online: 27 September 2024
Competing interests
: HT and WL are shareholders of Everglades Biopharma, LLC and LigandomicsRx, LLC. WL is an inventor of issued and pending patents. The remaining authors declare no competing financial interests.
: All animal experiments were conducted in accordance with NIH guidelines and approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.
